COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Safety and Efficacy of Repeated Infusion of CELYVIR in Children and Adults With Metastatic and Refractory Tumors.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01844661
Recruitment Status : Completed
First Posted : May 1, 2013
Last Update Posted : February 19, 2016
Instituto de Salud Carlos III
Information provided by (Responsible Party):
Manuel Ramírez, MD PhD, Hospital Infantil Universitario Niño Jesús, Madrid, Spain